阅读说明：本技术 原发性中枢神经系统淋巴瘤的组合治疗 (Combination therapy for primary central nervous system lymphoma ) 是由 A·科蒂 A·J·M·费雷利 于 2019-12-02 设计创作，主要内容包括：本发明涉及用于治疗原发性中枢神经系统淋巴瘤,优选为复发/难治性原发性中枢神经系统淋巴瘤的R-CHOP治疗和NGR-hTNF或其类似物给药的组合。(The present invention relates to a combination of R-CHOP treatment and NGR-hTNF or an analogue thereof for the treatment of primary central nervous system lymphoma, preferably relapsed/refractory primary central nervous system lymphoma.)